Works by Li-Weber, Min

Results: 21

NF-κB synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells.

Published in:

European Journal of Immunology, 2004, v. 34, n. 4, p. 1111, doi. 10.1002/eji.200324687

By:

Li-Weber, Min;
Giaisi, Marco;
Baumann, Sven;
Pálfi, Katalin;
Krammer, Peter H.

Publication type:

Article

The anti-inflammatory sesquiterpene lactone parthenolide suppresses IL-4 gene expression in peripheral blood T cells.

Published in:

European Journal of Immunology, 2002, v. 32, n. 12, p. 3587, doi. 10.1002/1521-4141(200212)32:12<3587::AID-IMMU3587>3.0.CO;2-E

By:

Li-Weber, Min;
Giaisi, Marco;
Treiber, Monika K.;
Krammer, Peter H.

Publication type:

Article

Vitamin E inhibits IL-4 gene expression in peripheral blood T cells.

Published in:

European Journal of Immunology, 2002, v. 32, n. 9, p. 2401, doi. 10.1002/1521-4141(200209)32:9<2401::AID-IMMU2401>3.0.CO;2-S

By:

Li-Weber, Min;
Giaisi, Marco;
Treiber, Monika K.;
Krammer, Peter H.

Publication type:

Article

Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene.

Published in:

European Journal of Immunology, 2001, v. 31, n. 12, p. 3694, doi. 10.1002/1521-4141(200112)31:12<3694::AID-IMMU3694>3.0.CO;2-S

By:

Li-Weber, Min;
Giaisi, Marco;
Krammer, Peter H.

Publication type:

Article

Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells.

Published in:

European Journal of Immunology, 2001, v. 31, n. 9, p. 2623, doi. 10.1002/1521-4141(200109)31:9<2623::AID-IMMU2623>3.0.CO;2-4

By:

Li-Weber, Min;
Giaisi, Marco;
Chlichlia, Katerina;
Khazaie, Khashayarsha;
Krammer, Peter H.

Publication type:

Article

The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat.

Published in:

European Journal of Immunology, 2001, v. 31, n. 6, p. 1790, doi. 10.1002/1521-4141(200106)31:6<1790::AID-IMMU1790>3.0.CO;2-G

By:

Ehret, Andreas;
Li-Weber, Min;
Frank, Rainer;
Krammer, Peter H.

Publication type:

Article

Up-regulation of c-FLIP.

Published in:

European Journal of Immunology, 2000, v. 30, n. 10, p. 2765, doi. 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W

By:

Kirchhoff, Sabine;
Müller, Wolfgang W.;
Li-Weber, Min;
Krammer, Peter H.

Publication type:

Article

T cell activation-induced and HIV Tat-enhanced CD95(APO-1 / Fas) ligand transcription involves NF-κB.

Published in:

European Journal of Immunology, 2000, v. 30, n. 2, p. 661, doi. 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L

By:

Li-Weber, Min;
Laur, Oskar;
Dern, Kirsten;
Krammer, Peter H.

Publication type:

Article

Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.

Published in:

European Journal of Immunology, 1999, v. 29, n. 9, p. 3017, doi. 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R

By:

Li-Weber, Min;
Laur, Oskar;
Krammer, Peter H.

Publication type:

Article

A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.

Published in:

European Journal of Immunology, 1998, v. 28, n. 8, p. 2373, doi. 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T

By:

Li-Weber, Min;
Laur, Oskar;
Hekele, Armin;
Coy, Johannes;
Walczak, Henning;
Krammer, Peter H.

Publication type:

Article

Treatment resistance analysis reveals GLUT‐1‐mediated glucose uptake as a major target of synthetic rocaglates in cancer cells.

Published in:

Cancer Medicine, 2021, v. 10, n. 19, p. 6807, doi. 10.1002/cam4.4212

By:

Sieber‐Frank, Julia;
Stark, Hans‐Jürgen;
Kalteis, Simon;
Prigge, Elena‐Sophie;
Köhler, Richard;
Andresen, Carolin;
Henkel, Thomas;
Casari, Georg;
Schubert, Tobias;
Fischl, Wolfgang;
Li‐Weber, Min;
Krammer, Peter H.;
von Knebel Doeberitz, Magnus;
Kopitz, Jürgen;
Kloor, Matthias;
Ahadova, Aysel

Publication type:

Article

HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.

Published in:

International Journal of Cancer, 2016, v. 138, n. 2, p. 507, doi. 10.1002/ijc.29726

By:

Witzens‐Harig, Mathias;
Giaisi, Marco;
Köhler, Rebecca;
Krammer, Peter H.;
Li‐Weber, Min

Publication type:

Article

Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growth via ROS-mediated apoptosis and ATM/ATR-Chk1/Chk2-regulated cell cycle arrest.

Published in:

International Journal of Cancer, 2015, v. 137, n. 11, p. 2739, doi. 10.1002/ijc.29629

By:

Neumann, Jennifer;
Yang, Yi;
Köhler, Rebecca;
Giaisi, Marco;
Witzens‐Harig, Mathias;
Liu, Dong;
Krammer, Peter H.;
Lin, Wenhan;
Li‐Weber, Min

Publication type:

Article

Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).

Published in:

International Journal of Cancer, 2015, v. 137, n. 8, p. 1791, doi. 10.1002/ijc.29013

By:

Li‐Weber, Min

Publication type:

Article

Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.

Published in:

International Journal of Cancer, 2015, v. 136, n. 3, p. 688, doi. 10.1002/ijc.29009

By:

Polier, Gernot;
Giaisi, Marco;
Köhler, Rebecca;
Müller, Wolfgang W.;
Lutz, Christoph;
Buss, Eike C.;
Krammer, Peter H.;
Li‐Weber, Min

Publication type:

Article

The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.

Published in:

International Journal of Cancer, 2014, v. 134, n. 8, p. 1991, doi. 10.1002/ijc.28521

By:

Neumann, Jennifer;
Boerries, Melanie;
Köhler, Rebecca;
Giaisi, Marco;
Krammer, Peter H.;
Busch, Hauke;
Li‐Weber, Min

Publication type:

Article

The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.

Published in:

International Journal of Cancer, 2014, v. 134, n. 2, p. 291, doi. 10.1002/ijc.28379

By:

Bourkoula, Konstantina;
Englert, Christoph;
Giaisi, Marco;
Köhler, Rebecca;
Krammer, Peter H.;
Li ‐ Weber, Min

Publication type:

Article

Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.

Published in:

International Journal of Cancer, 2013, v. 133, n. 8, p. 1945, doi. 10.1002/ijc.28189

By:

Natoli, Antonino;
Lüpertz, Regine;
Merz, Christian;
Müller, Wolfgang W.;
Köhler, Rebecca;
Krammer, Peter H.;
Li‐Weber, Min

Publication type:

Article

Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.

Published in:

International Journal of Cancer, 2012, v. 131, n. 4, p. 1003, doi. 10.1002/ijc.26458

By:

Giaisi, Marco;
Köhler, Rebecca;
Fulda, Simone;
Krammer, Peter H.;
Li-Weber, Min

Publication type:

Article

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities.

Published in:

International Journal of Cancer, 2007, v. 121, n. 8, p. 1839, doi. 10.1002/ijc.22883

By:

Zhu, Jia Y.;
Lavrik, Inna N.;
Mahlknecht, Ulrich;
Giaisi, Marco;
Proksch, Peter;
Krammer, Peter H.;
Li-Weber, Min

Publication type:

Article

Regulation of IL4 gene expression by T cells and therapeutic perspectives.

Published in:

Nature Reviews Immunology, 2003, v. 3, n. 7, p. 534, doi. 10.1038/nri1128

By:

Li-Weber, Min;
Krammer, Peter H.

Publication type:

Article